105.04 USD
↘ 1.95 (1.82%)AT CLOSE (11:59 AM EDT)
Abivax SA American Depositary Shares
ABVXNASDAQ • USD
104.82
↘ 0.23 (0.21%)
POST MARKET (AS OF 07:49 PM EDT)
Post Market
AS OF 07:49 PM EDT
104.82
↘ 0.23 (0.21%)
Market: CLOSED
ABVX is currently priced at $105.04. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. This is driven by a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Sep 18, 2026.
Open?$107.00
High?$107.19
Low?$103.89
Prev. Close?$106.99
Volume?876.0K
Avg. Volume?N/A
VWAP?$104.93
Bid / Ask
Bid?$103.80 × 300
Ask?$105.77 × 100
Spread?$1.97
Midpoint?$104.79
Valuation & Ratios
Market Cap?9.2B
Shares Out?87.4M
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestHigh
Short Interest?7.0M
Days to Cover?8.0
Avg Daily Volume873.6K
Settlement Date2026-08-31